Home
Vascular Pharmaceuticals, Inc.

Vascular Pharmaceuticals... Market Share Analysis for May 2026

Industry: N/A

Domainvascularpharma.com

Year Founded2005

Employees51 - 200

Annual Revenue$25M - $50M

Vascular Pharmaceuticals, Inc.

Vascular Pharmaceuticals, Inc. (including company regionals)

vascularpharma.com

See more website traffic and engagement information

Vascular Pharmaceuticals, Inc. Revenue up to May 2026 is 25M - 50M

revenue generated by Vascular Pharmaceuticals, Inc. top domains

Vascular Pharmaceuticals, Inc. top domains revenue over 3 years

Revenue for Vascular Pharmaceuticals, Inc. top domains

vascularpharma.com25M - 50M

See more with Sales Intelligence

Total visits to Vascular Pharmaceuticals, Inc.'s top domains

Understand Vascular Pharmaceuticals, Inc. market share and potential market reach.

Total visits last 3 months

Subsidiaries Breakdown

vascularpharma.com738

See more with Sales Intelligence

Avg. visit duration in Vascular Pharmaceuticals, Inc.'s top domains

Analyze Vascular Pharmaceuticals, Inc. engagement metrics.

Average visit duration last 3 months

No Data to Display

Avg. pageviews on Vascular Pharmaceuticals, Inc.'s top domains

See how Vascular Pharmaceuticals, Inc. keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

Subsidiaries Breakdown

vascularpharma.com1.04

See more with Sales Intelligence

Vascular Pharmaceuticals, Inc. top competitors by domain

Looks like there’s not enough data here

No Data to Display

Top technologies used by Vascular Pharmaceuticals, Inc.

These are the website technologies, by industry, used by Vascular Pharmaceuticals, Inc. top domains

Content Management System (1)

WordPress

Mobile (1)

Meta Viewport

Other (1)

Google API

Widget (1)

Twemoji

News & Signals from Vascular Pharmaceuticals, Inc.

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsVascular Pharmaceuticals, Inc. received financing of $9M in Series A Plus on Feb 3rd '15.CHAPEL HILL, NC, March 2, 2015, Vascular Pharmaceuticals, Inc. (VPI), a clinical-stage pharmaceutical company addressing the complications of diabetes, announced today that it has increased its Series A financing with the addition of a $9.0 million expansion round.

NewsVascular Pharmaceuticals, Inc. hires Richard Kent as Board of Directors.Richard Kent, M.D., Partner at Intersouth Partners and Vaughn Kailian, Managing Director of MPM Capital, will join Vascular Pharma's Board of Directors.